These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12133407)

  • 1. [Anticancer effects of cytosine deaminase gene/5-fluorocytosine therapies to ovarian cancer in vivo].
    Yao Y; Peng Z; Wang H; Li Q; Liu S
    Zhonghua Fu Chan Ke Za Zhi; 2002 Apr; 37(4):195-7. PubMed ID: 12133407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
    Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
    Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001.
    Cunningham C; Nemunaitis J
    Hum Gene Ther; 2001 Aug; 12(12):1594-6. PubMed ID: 11529249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.
    Hanna NN; Mauceri HJ; Wayne JD; Hallahan DE; Kufe DW; Weichselbaum RR
    Cancer Res; 1997 Oct; 57(19):4205-9. PubMed ID: 9331076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model.
    Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Yamaue H; Tanimura H
    Cancer Res; 2001 Aug; 61(16):6158-62. PubMed ID: 11507067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine.
    Koyama F; Sawada H; Hirao T; Fujii H; Hamada H; Nakano H
    Cancer Gene Ther; 2000 Jul; 7(7):1015-22. PubMed ID: 10917204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravenous delivery of cationic liposomes conjugation to recombinant adenoviral vectors containing human endostatin gene inhibits ovarian cancer growth in nude mice].
    Wang L; Yang L; Wu YK; Zhao X; Wei YQ; Li W; Tian Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):190-4. PubMed ID: 19462887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approach.
    Anderson LM; Krotz S; Weitzman SA; Thimmapaya B
    Cancer Gene Ther; 2000 Jun; 7(6):845-52. PubMed ID: 10880014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
    Akbulut H; Zhang L; Tang Y; Deisseroth A
    Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticancer efficacy of combining cytosine deaminase/5-fluorocytosine gene therapy and radiotherapy on cervical carcinoma].
    Gao XL; Li QL; Peng ZL; Wang H
    Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):761-4. PubMed ID: 16324251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic effect of 5-fluorocytosine on cytosine deaminase gene transduced Wilms' tumor xenograft in nude mice].
    Bi Y; Gao J; Xu D
    Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):113-5. PubMed ID: 11776635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase.
    Chung-Faye GA; Chen MJ; Green NK; Burton A; Anderson D; Mautner V; Searle PF; Kerr DJ
    Gene Ther; 2001 Oct; 8(20):1547-54. PubMed ID: 11704815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional 'pro-drug' gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma.
    Topf N; Worgall S; Hackett NR; Crystal RG
    Gene Ther; 1998 Apr; 5(4):507-13. PubMed ID: 9614575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.
    Peng XY; Won JH; Rutherford T; Fujii T; Zelterman D; Pizzorno G; Sapi E; Leavitt J; Kacinski B; Crystal R; Schwartz P; Deisseroth A
    Cancer Res; 2001 Jun; 61(11):4405-13. PubMed ID: 11389068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory.
    Consalvo M; Mullen CA; Modesti A; Musiani P; Allione A; Cavallo F; Giovarelli M; Forni G
    J Immunol; 1995 May; 154(10):5302-12. PubMed ID: 7730633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme/prodrug gene therapy for human colon cancer cells using adenovirus-mediated transfer of the Escherichia coli cytosine deaminase gene driven by a CAG promoter associated with 5-fluorocytosine administration.
    Koyama F; Sawada H; Fujii H; Hirao T; Ueno M; Hamada H; Nakano H
    J Exp Clin Cancer Res; 2000 Mar; 19(1):75-80. PubMed ID: 10840940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for human hepatocellular carcinoma with cytosine deaminase gene and prodrug flucytosine.
    Lü HZ; Wu DZ; Wan YL; Gu B; Gao HZ; Liang YQ; Wang JX
    Zhongguo Yao Li Xue Bao; 1999 May; 20(5):440-4. PubMed ID: 10678093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effect of AdCMVCD/5-FC system and metabolism of 5-FC in the treatment of human tongue squamous cell carcinoma.
    Wang A; Huang H; Li S
    Chin Med J (Engl); 2003 Feb; 116(2):248-52. PubMed ID: 12775241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase.
    Huber BE; Austin EA; Good SS; Knick VC; Tibbels S; Richards CA
    Cancer Res; 1993 Oct; 53(19):4619-26. PubMed ID: 8402637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
    You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.